Scientists search for blood clues in Muscle-Weakening disease treatment
NCT ID NCT07337395
First seen Jan 15, 2026 · Last updated Apr 11, 2026 · Updated 14 times
Summary
This study aims to understand how the drug ravulizumab affects people with generalized myasthenia gravis, a condition that causes muscle weakness. Researchers will analyze blood samples from 24 adult patients before and during treatment to look for changes in proteins that might indicate how well the treatment is working. The goal is to find biological markers that could help doctors monitor treatment response and understand the body's repair processes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS GENERALISED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, 00168, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.